Somnus Medical Technologies, Inc. designs, develops, manufactures, and markets medical devices that utilize its proprietary radio frequency technology for the treatment of upper airway disorders. The Company's "Somnoplasty System" provides physicians with a suite of products which offer minimally-invasive, curative treatment alternatives for snoring, and other disorders of the upper airway. Source-Bloomberg-http://www.bloomberg.com/quote/SOMN:US/profile

ArthroCare develops and manufactures surgical devices, instruments, and implants that strive to enhance surgical techniques as well as improve patient outcomes. Its devices improve many existing surgical procedures and enable new minimally invasive procedures. Many of ArthroCare's devices use its internationally patented Coblation (R) technology. This technology precisely dissolves target tissue and limits damage to surrounding healthy tissue. ArthroCare also develops surgical devices utilizing other patented technology including its OPUS (R) line of fixation products as well as re-usable surgical instruments. ArthroCare is leveraging these technologies in order to offer a comprehensive line of surgical devices to capitalize on a multi-billion dollar market opportunity across several surgical specialties, including its two core product areas consisting of Sports Medicine and Ear, Nose, and Throat as well as other areas such as spine, wound care, urology and gynecology.

Acclarent, Inc. is a medical device company in Menlo Park, CA that was established in June of 2004. The company is dedicated to the development of innovative devices providing new technologies to further meet the needs of ENT patients. Acclarent's initial focus is on achieving the goals of sinus surgery with novel, endoscopic, catheter-based tools - Balloon Sinuplastyâ„¢ devices. Through the Balloon Sinuplastyâ„¢ technology and our RelievaÂ:registered: product portfolio we offer ENT patients alternatives to conventional endoscopic surgical approaches. FDA clearances for these devices were completed in 2005 and the products were commercially launched in the US that same year. Through our core technologies and commitment to innovation, Acclarent will continue to advance novel devices in all areas of ENT.

Cellatoz Therapeutics with the goal of resolving the unmet medical needs of incurable diseases. Korea's top R & D specialists gather to discover differentiated therapeutic cell and platform technologies, and promote the commercialization of cell therapy products based on the company's intermediary research and product development capabilities.Cellatoz Therapeutics are the first in the world to acquire musculoskeletal stem cell (MSSC) induction technology capable of final differentiation from embryonic stem cells and inducible pluripotent stem cells (iPSC) into mesodermal tissue cells. By modulating the cell differentiation signals of the cells, we are developing a therapeutic agent for musculoskeletal-related diseases (eg compound fracture, arthritic cartilage damage, etc.) that can regenerate and repair the tissue of the musculoskeletal injured area.

AntiCancer, Inc. operates as a biotechnology company. It develops drugs for cancer based on genetic engineering and targeting cancer specific metabolic defects. The company provides Oncobriteâ, a small-animal imaging technology; MetaMouseâ and ANGIOMOUSEâ that are mouse models of human cancer; Histoculture Drug Response Assay, an individualized cancer therapy; Oncase-PEGâ, a recombinant protein that depletes methionine in tumors; stem cells for general regenerative medicine; tumor-targeting bacteria; and Dermatek, a liposome-based hair-follicle targeting technology. It also offers Enzymatic Homocysteine, Enzymatic B6, and Enzymatic cysteine assays.

MD Healthcare, Inc. is engaged in developing innovative precision medical solutions based on micro biome data. The company was founded in January, 2014 and is headquartered in Seoul, South Korea.

Intersect ENT, Inc. is a commercial drug delivery company, which engages in the treatment of ear, nose, and throat conditions. Its products include PROPEL and SINUVA. The PROPEL used to maintain the opening and locally deliver steroid after sinus surgery. The SINUVA is used to treat adult patients with ethmoid sinus surgery yet suffer from recurrent sinus obstruction due to polyps. The company was founded by Donald J. Eaton in October 2003 and is headquartered in Menlo Park, CA.

Part of Medtronic Plc, Covidien Pte Ltd. is a Singaporean company located in Singapore that manufactures and supplies medical equipment.

Provides research and development services for pharmaceutical preparations

Manufactures and wholesales medical devices

PEAK Surgical is a medical device company that has developed the PEAK Surgery System, a new tissue dissection system based on a proprietary technology that represents an important advance in radiofrequency surgical technologies. The PEAK Surgery System consists of the PEAK PlasmaBlade, a family of disposable cutting devices that offer the exacting control of a scalpel and the bleeding control of traditional electrosurgery without extensive collateral damage, and the PULSAR Generator, which supplies pulsed plasma radiofrequency energy to the PlasmaBlade. The PEAK Surgery System is cleared for use in general, plastic and reconstructive, ENT, gynecologic, orthopedic, arthroscopic, spinal and neurological surgical procedures in the United States, and for use in general surgery in the European Union. It was launched in the United States in July 2008 and has been used by U.S. surgeons on many patients, including general, gynecologic, orthopedic and plastic and reconstructive surgeries

Part of Medtronic Plc, Medtronic Advanced Energy LLC is a company headquartered in the United States that develops and markets surgical products.

Medtronic Xomed, Inc. manufactured and distributed surgical products. It offered powered tissue-removal systems, microendoscopy instruments, implantable devices, nerve monitoring systems, disposable fluid-control metal, and image-guided surgery system products. The company was headquartered in Jacksonville, FL.

Cangzhou Aoke Medical Equipment Co., Ltd., established on 2005-12-19, Business scope includes production:Class III:6825-1High Frequency Surgical and Coagulation Equipment**(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Hunan Lanlinge Medical Technology Co., Ltd., established on 2015-12-30, The scope of business includes a class of medical devices,medicine,oral hygiene products,Chinese medicine,Healthy food,disinfectant,Class II medical device,hygiene products,Health products,Food Safety Testing Products,cosmetic,Research and development of network technology;Textile,Clothing and daily necessities,Pre-packaged food,imported food,Retailing of Domestic Liquor;nutritious food,Manufacture of sanitary materials and medical supplies;Healthy food,disinfection products,hygiene products,sanitary equipment,Production of health care products;Cosmetics and hygiene products,Sanitation products,Wholesale of electronic products;Class I medical device,Class II medical device,Class III Medical Devices,agricultural products,Sales of nutritional and health food;Food Science and Technology Research Services;Agricultural product delivery;Organization and planning of cultural activities;Enterprise Marketing Planning;Industrial Design Services;Company etiquette service;Advertising production service;Nutrition and Health Consulting Services;medical consultation;Health and Wellness Consulting(Does not contain medical diagnoses);Medical device technology promotion service;Economic and business consulting services;Meeting,Exhibition and related services;Realtor;Chinese clinic;Traditional Chinese medicine service;Traditional Chinese Medicine Health Care Services(non-medical).(Do not engage in unauthorizedP2Ponline loan,Equity crowdfunding,internet insurance,Asset management and cross-border finance,Third party payment,virtual currency transaction,ICO,Internet financial services such as illegal foreign exchange)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

The 301 Hospital (Chinese: 三〇一医院) or People's Liberation Army General Hospital (Chinese: 中国人民解放军总医院), which constitutes simultaneously the PLA Postgraduate Medical School (Chinese: 中国人民解放军医学院), located in Beijing, China, is a military hospital directly subsidiary to Logistic Support Department of the Central Military Commission and the largest general hospital under the auspices of the People's Liberation Army. Its mission includes assuring the health of PLA and China's leaders.

Bavarian Nordic A/S focuses on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases. It specializes in cancer immunotherapy which includes cancer pipeline, which focuses on therapeutic vaccines for breast, lung, ovarian and prostate cancer. Its products include IMVAMUNE for Ebola, HPV, HBV, and HIV diseases. The company was founded in 1994 and is headquartered in Kvistgaard, Denmark.

Nanjing Children's Hospital Ltd. is a Chinese private company located in Nanjing that provides healthcare services.